1. Ahn, C. M. and Kim, S. K., Synthesis andin vitro antitumor activity of isoazamitosene and isoiminoazamitosene derivatives.Arch. Pharm. Res., 19, 535–542 (1996).
2. Carmichael, J., deGraff, W. G., Gazdar, A. F., Minna, J. D., Mitchel, J. B., Evaluation of a tetrazolium-based semiautomated colorimetric assay; assessment of radiosenstivity.Cancer Res., 47, 936–942, (1987).
3. Carrato, A., Diaz-Rubio, E., Medrano, J., Phase III trial of surgery versus adjuvant chemotherapy with mitomycin C and tegafur plus uracil, strating first week fater surgery, for gastric adenocarcinoma.Proc. Am. Soc. Clin. Oncol., 14, 198 (1995).
4. Cha, D. S., Kim, S. K., Ahn, C. M., Choi, S. J., Park, Y. S., Han, S. W.,In vitro growth inhibition of mitosene analogues on human ovarian cancer cell lines.J. Kor. Cancer Assoc., 29, 437–444 (1997).
5. Islam, I. and Skibo, E. B., Synthesis and physical studies of azamitosenes and iminoazamitosene reductive alkylating agents. Iminoquinone hydrolytic stability, syn/anti isomerization, and electrochemistry.J. Org. Chem., 55, 3195–3205 (1990).